Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 8/20 | 0.57 |
| ▸ | TERT | O14746 | 1/20 | 0.48 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.48 |
| ▸ | KLK1 | P06870 | 1/20 | 0.45 |
| ▸ | KLK5 | Q9Y337 | 1/20 | 0.45 |
| ▸ | FPR2 | P25090 | 1/20 | 0.44 |
| ▸ | FDPS | P14324 | 1/20 | 0.41 |
| ▸ | TBXAS1 | P24557 | 2/20 | 0.40 |
| ▸ | HTR1A | P08908 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL369710 | 0.91 | TAAR1 (0.53) | TAAR1TERTALOX15KLK1KLK5 | |
| SCHEMBL5355358 | 0.89 | TAAR1 (0.52) | TAAR1TERTALOX15KLK1KLK5 | |
| SCHEMBL1040322 | 0.87 | — | — | |
| SCHEMBL4775864 | 0.85 | TERT (0.59) | TAAR1TERTALOX15KLK1KLK5 | |
| SCHEMBL2475485 | 0.84 | TAAR1 (0.62) | TAAR1ALDH1A1SMN1; SMN2 | |
| SCHEMBL4985592 | 0.83 | TAAR1 (0.47) | TAAR1TERTALOX15KLK1KLK5 | |
| SCHEMBL1971764 | 0.83 | TAAR1 (0.47) | TAAR1TERTALOX15KLK1KLK5 | |
| SCHEMBL6225559 | 0.83 | TAAR1 (0.47) | TAAR1TERTALOX15KLK1KLK5 | |
| SCHEMBL7748015 | 0.82 | TAAR1 (0.46) | TAAR1TERTALOX15KLK1KLK5 | |
| Ammonia Solution, Strong SCHEMBL28870904 | 0.82 | TAAR1 (0.46) | TAAR1TERTALOX15KLK1KLK5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 98 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150110716-A1 | METHODS OF USING SPECT/CT ANALYSIS FOR STAGING CANCER | MOLECULAR INSIGHT PHARMACEUTICALS, INC. (US) | 2015-04-23 | — | — | US | claimed |
| US-20100098633-A1 | SELECTIVE SEPRASE INHIBITORS | MOLECULAR INSIGHT PHARMACEUTICALS, INC. | 2010-04-22 | — | — | US | claimed |
| US-5708022-A | RUTHENIUM COMPLEXES | PROCEPT, INC. (US) | 1998-01-13 | — | — | US | claimed |
| WO-1996013510-A1 | RUTHENIUM COMPLEXES AND THEIR USE AS IMMUNOSUPPRESSIVE AGENTS | PROCEPT, INC. (US) | 1996-05-09 | — | — | WO | claimed |
| US-20240327549-A1 | METAL-CONTAINING POLYMERS FOR MASS CYTOMETRY | STANDARD BIOTOOLS CANADA INC. (CA) | 2024-10-03 | — | — | US | disclosed |
| EP-4367164-A1 | METAL-CONTAINING POLYMERS FOR MASS CYTOMETRY | The Governing Council of the University of Toronto (CA) | 2024-05-15 | — | — | EP | disclosed |
| CN-117820098-A | Method for preparing linear aldehyde by olefin selective hydroformylation | 复旦大学 | 2024-04-05 | — | — | CN | disclosed |
| CN-117813339-A | Metal-containing polymers for mass flow cytometry | 多伦多大学理事会 | 2024-04-02 | — | — | CN | disclosed |
| WO-2023279211-A1 | METAL-CONTAINING POLYMERS FOR MASS CYTOMETRY | THE GOVERNING COUNCIL OF THE UNIVERSITY OF TORONTO (CA) | 2023-01-12 | — | — | WO | disclosed |
| US-10184052-B2 | Near infrared radiation-absorbing composition, near infrared radiation cut-off filter and production method therefor, and camera module and production method therefor | FUJIFILM CORPORATION (JP) | 2019-01-22 | — | — | US | disclosed |
| US-20180094086-A1 | NEAR INFRARED ABSORBING COMPOSITION, NEAR INFRARED CUT FILTER, METHOD OF MANUFACTURING NEAR INFRARED CUT FILTER, DEVICE, METHOD OF MANUFACTURING COPPER-CONTAINING POLYMER, AND COPPER-CONTAINING POLYMER | FUJIFILM CORPORATION (JP) | 2018-04-05 | — | — | US | disclosed |
| US-20170227690-A1 | NEAR INFRARED RAY ABSORBENT COMPOSITION, NEAR INFRARED RAY CUT FILTER, SOLID IMAGE PICKUP ELEMENT, AND CAMERA MODULE | FUJIFILM CORPORATION (JP) | 2017-08-10 | — | — | US | disclosed |
| US-5512687-A | RUTHENIUM COMPLEXES | PROCEPT, INC. (US) | 1996-04-30 | — | — | US | disclosed |
| WO-1996006157-A1 | DETERGENT BLEACH COMPOSITION | UNILEVER N.V. (NL) | 1996-02-29 | — | — | WO | disclosed |
| WO-1996006154-A1 | DETERGENT BLEACH COMPOSITION | UNILEVER N.V. (NL) | 1996-02-29 | — | — | WO | disclosed |
| US-5274147-A | Reacting a manganese(III) salt with a ligand and oxidizing the complex with hydrogen peroxide | LEVER BROTHERS COMPANY, DIVISION OF CONOPCO, INC. (US) | 1993-12-28 | — | — | US | disclosed |
| US-5244594-A | BLEACH ACTIVATION MULTINUCLEAR MANGANESE-BASED COORDINATION COMPLEXES | LEVER BROTHERS COMPANY, DIVISION OF CONOPCO, INC. (US) | 1993-09-14 | — | — | US | disclosed |
| EP-0544490-A1 | Detergent bleach compositions | UNILEVER PLC (GB) | 1993-06-02 | — | — | EP | disclosed |
| EP-0522817-A1 | Process for preparing manganese complexes | UNILEVER PLC (GB) | 1993-01-13 | — | — | EP | disclosed |
| EP-0458398-A2 | Bleach activation | UNILEVER N.V. (NL) | 1991-11-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100098633-A1 | SELECTIVE SEPRASE INHIBITORS | SLC6A7, DNPEP, PREP | TAAR1 1716/4885TERT 4403/4885ALOX15 4302/4885 |
| US-20150110716-A1 | METHODS OF USING SPECT/CT ANALYSIS FOR STAGING CANCER | KLK3, SHBG, FOLH1 | TAAR1 1861/4885TERT 3314/4885ALOX15 4759/4885 |
| US-20170227690-A1 | NEAR INFRARED RAY ABSORBENT COMPOSITION, NEAR INFRARED RAY CUT FILTER, SOLID IMAGE PICKUP ELEMENT, AND CAMERA MODULE | C9, SET, CRY1 | TAAR1 3067/4885TERT 2680/4885ALOX15 2928/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.